These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1174840)

  • 21. Letter: Medical management of transient ischaemic attacks.
    Kendall MJ
    Br Med J; 1975 Mar; 1(5960):737. PubMed ID: 1125691
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis.
    Teo CP; Lim HL; Kueh YK
    Thromb Haemost; 1994 Aug; 72(2):328-9. PubMed ID: 7831676
    [No Abstract]   [Full Text] [Related]  

  • 23. A controlled trial of the effect of calmic 131A in the treatment of transient cerebral ischaemic attacks.
    Millar JH; Wilson HE
    J Atheroscler Res; 1968; 8(1):192-5. PubMed ID: 4868111
    [No Abstract]   [Full Text] [Related]  

  • 24. Ischemic stroke associated with brief cessation of warfarin.
    Yasaka M; Naritomi H; Minematsu K
    Thromb Res; 2006; 118(2):290-3. PubMed ID: 16197984
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin.
    Eikelboom JW; Bosch J
    Evid Based Med; 2015 Jun; 20(3):117. PubMed ID: 25870161
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of cerebral ischemia.
    Hinton RC
    Compr Ther; 1981 Apr; 7(4):24-31. PubMed ID: 6165515
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute ischemic stroke and heparin treatments.
    Samama MM; Desnoyers PC; Conard J; Bousser MG
    Thromb Haemost; 1997 Jul; 78(1):173-9. PubMed ID: 9198148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quick action stressed for transient ischemic attack victims.
    Curr Probl Cardiol; 1983 Oct; 8(7):78-80. PubMed ID: 6641275
    [No Abstract]   [Full Text] [Related]  

  • 30. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
    Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Lane DA; Lip GY
    Am J Med; 2014 Dec; 127(12):1172-8.e5. PubMed ID: 25193361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient cerebral ischaemic attacks--management and prognosis.
    Roden S; Low-Beer T; Carmalt M; Cockel R; Green I
    Postgrad Med J; 1981 May; 57(667):275-8. PubMed ID: 7029501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
    Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulant therapy of cerebral infarction: report of a national cooperative study.
    Baker RN; Broward JA; Fang HC; Fisher CM; Groch SN; Heyman A; Karp HR; McDevitt E; Scheinberg P; Schwartz W; Toole JF
    Res Publ Assoc Res Nerv Ment Dis; 1966; 41():287-302. PubMed ID: 4163327
    [No Abstract]   [Full Text] [Related]  

  • 34. Controversies in the medical management of stroke.
    West J Med; 1985 Jan; 142(1):74-8. PubMed ID: 3976222
    [No Abstract]   [Full Text] [Related]  

  • 35. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
    Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
    Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant and defibrinogenating agents in acute ischemic stroke and cerebral venous thrombosis.
    Meschia JF
    Semin Neurol; 1998; 18(4):461-70. PubMed ID: 9932617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term outcome of medically treated patients with transient ischemic attacks, reversible ischemic neurologic deficits and strokes with minimum residuum.
    Calandre L; Molina JA
    Eur Neurol; 1985; 24(4):281-5. PubMed ID: 2408892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparinization and incidence of thromboembolism in left cardiac catheterization by femoral percutaneous technic].
    Esplugas E; Barthe JE; Jara F; Sabate J
    Rev Esp Cardiol; 1979; 32(6):571-5. PubMed ID: 542687
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating thromboembolic disease.
    Deykin D; Gurewich V; Harker L; Hirsch J
    Geriatrics; 1977 Oct; 32(10):119-21, 125-8. PubMed ID: 302814
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes.
    Sivenius J; Riekkinen PJ; Laakso M
    BMJ; 1995 Jan; 310(6971):25-6. PubMed ID: 7827549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.